That this is an unfamiliar and uncomfortable environment for many investors goes without saying. It was unforeseen to the extent that it is at odds with recent experience. For passive investors, the...
Chemicals and Fertilizing stocks have been among the sectors that seem to be "benefiting" from supply shocks in the system stemming from the war in Ukraine, as well as just general inflation touching the price of everything (except tech stocks,...
The largest insider buy on today's list is a Form 4 filing by Column Group, which reported the purchase of approximately $5.8 million in NGM Biopharmaceuticals $NGM.
Kevin Riley, the CEO and president of First Interstate BancSystem $FIBK,...
Key Takeaway: Investor moods will change as prices fluctuate but they seemed to follow word with deed in May. The AAII asset allocation survey showed them lightening up (perhaps only...
Longtime readers know how much we love new monthly candlesticks. They force us to zoom out from the day-to-day noise and focus on what's really taking place.
We play with the cards we are dealt. There is nothing else we can do. We cannot employ willpower to create market conditions into being the way we'd prefer them to be. They are what they are, it is what it is. So we work with what we've got.
